Last updated on May 2019

Efficacy and Systemic Safety of Netarsudil 0.01% 0.02% 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan


Brief description of study

Test ocular hypotensive efficacy and systemic safety of netarsudil 0.01%, 0.02%, 0.04% relative to placebo in subjects with open-angle glaucoma or ocular hypertension in Japan

Clinical Study Identifier: NCT03844945

Find a site near you

Start Over

Hangai Eye Institute

Saitama-shi, Japan
3.54miles
  Connect »

Omiya Hamada Eye Clinic

Saitama-shi, Japan
3.54miles
  Connect »

Shibuya Ophthalmology Clinic

Saitama-shi, Japan
3.54miles
  Connect »

Ueda Eye Clinic

Arakawa-ku, Japan
8.18miles
  Connect »

Ochanomizu Inoue Eye Clinic

Chiyoda-ku, Japan
9.54miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.